GENEVA, Sept. 28 -- MYROBALAN THERAPEUTICS (NANJING) CO., LTD. (Room 695, Building A, Phase I, Zhongdan Ecological Life Science Industrial Park, 3-1 Xinjinhu Road, Jiangbei New AreaNanjing, Jiangsu 210031), 迈巴制药（南京）有限公司 (中国江苏省南京市江北新区新锦湖路3-1号中丹生态生命科学产业园一期A栋695室) filed a patent application (PCT/CN2025/081976) for "GPR17 RECEPTOR INHIBITOR AND USE THEREOF" on Mar 12, 2025. With publication no. WO/2025/195241, the details related to the paten...